Development
Treatment.com AI Inc.
TREIF
$0.3496
-$0.0034-0.96%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -97.28% | -66.41% | -43.39% | 56.70% | 122.21% |
| Gross Profit | 97.28% | 66.41% | 43.39% | -56.70% | -122.21% |
| SG&A Expenses | -85.23% | -86.49% | -74.70% | 8.69% | 249.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -87.52% | -86.20% | -73.01% | -3.72% | 153.62% |
| Operating Income | 87.52% | 86.20% | 73.01% | 3.72% | -153.62% |
| Income Before Tax | 86.75% | 85.53% | 72.91% | 3.61% | -153.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 86.75% | 85.53% | 72.91% | 3.61% | -153.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 86.75% | 85.53% | 72.91% | 3.61% | -153.97% |
| EBIT | 87.52% | 86.20% | 73.01% | 3.72% | -153.62% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 86.92% | 85.76% | 73.43% | 7.49% | -142.95% |
| Normalized Basic EPS | 87.04% | 85.87% | 73.05% | 6.48% | -145.14% |
| EPS Diluted | 86.92% | 85.76% | 73.43% | 7.49% | -142.95% |
| Normalized Diluted EPS | 87.04% | 85.87% | 73.05% | 6.48% | -145.14% |
| Average Basic Shares Outstanding | 0.98% | 1.63% | 2.62% | 5.14% | 6.09% |
| Average Diluted Shares Outstanding | 0.98% | 1.63% | 2.62% | 5.14% | 6.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |